FdaApplication
ANDA 214623
Identifiers
- fda_app_no: ANDA214623
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2022-02-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CARDIOPLEGIC IN PLASTIC CONTAINER | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE | 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML | SOLUTION;PERFUSION, CARDIAC |
1 product